Michael A. den Bakker

8.2k citations

109 papers · 3.2k indexed · h-index 35

Oncology top 2%
Pulmonary and Respiratory Medicine top 2%
Epidemiology top 5%
Molecular Biology
Neurology top 2%

Co-authors: Cornelis Verhoef John A. Foekens Stefan Sleijfer Winand N.M. Dinjens Alexander Marx Hans Gelderblom Jeroen S. Kloover Danique L. M. van Broekhoven
Topics: Sarcoma Diagnosis and Treatment (15 papers)Lung Cancer Research Studies (14 papers)Neuroendocrine Tumor Research Advances (13 papers)
Cited by: Oncology Rheumatology Neurology
Journals: Journal of Clinical Oncology Radiology Clinical Cancer Research
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Michael A. den Bakker

106 papers receiving 3.2k citations

Peers

Countries citing papers authored by Michael A. den Bakker

Since Specialization

Citations

This map shows the geographic impact of Michael A. den Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. den Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. den Bakker more than expected).

Fields of papers citing papers by Michael A. den Bakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. den Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. den Bakker. The network helps show where Michael A. den Bakker may publish in the future.

Co-authorship network of co-authors of Michael A. den Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. den Bakker. A scholar is included among the top collaborators of Michael A. den Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. den Bakker. Michael A. den Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid 2024 ·Modern Pathology ·Laura Moonen,Jules L. Derks,Michael A. den Bakker,Lisa M. Hillen,Robert Jan van Suylen,Jan H. von der Thüsen,(unknown),(unknown),Ronald Damhuis,Kim M. Smits,Esther C. van den Broek,Wieneke A. Buikhuisen,Anne‐Marie C. Dingemans,Ernst‐Jan M. Speel	3
2	Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids 2024 ·Journal of Thoracic Oncology ·(unknown),Laura Moonen,Jan H. von der Thüsen,Michael A. den Bakker,Lisa M. Hillen,(unknown),Axel zur Hausen,Thierry van den Bosch,(unknown),Ronald Damhuis,Niki L. Reynaert,Esther C. van den Broek,Lynnette Fernandez‐Cuesta,(unknown),(unknown),(unknown),Anne‐Marie C. Dingemans,(unknown),Jules L. Derks	6
3	Neurogenic tumours of the posterior mediastinum and differential diagnosis considerations 2023 ·Histopathology ·Michael A. den Bakker,Annikka Weissferdt	1
4	Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve‐sparing surgery 2023 ·Histopathology ·(unknown),Sebastiaan Remmers,Charlotte F. Kweldam,Michael A. den Bakker,Daan Nieboer,Martijn B. Busstra,M. Gan,Sjoerd Klaver,John Rietbergen,Geert J.L.H. van Leenders,(unknown)	4
5	Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer 2022 ·Cancers ·(unknown),Titia G. Meijer,Nicole S. Verkaik,(unknown),Carolien H. M. van Deurzen,Michael A. den Bakker,Roland Kanaar,Dik C. van Gent,Agnes Jager	5
6	Partial versus complete prostatectomy specimen sampling: prospective non-inferiority study for pT3a tumours and surgical margin involvement 2019 ·BMJ Open ·(unknown),Michael A. den Bakker,Sjoerd Klaver,André N. Vis,Mike Kliffen	4
7	Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects 2018 ·Clinical Cancer Research ·Titia G. Meijer,Nicole S. Verkaik,Anieta M. Sieuwerts,Job van Riet,Kishan A.T. Naipal,Carolien H. M. van Deurzen,Michael A. den Bakker,Hein F.B.M. Sleddens,(unknown),(unknown),Winand N.M. Dinjens,Esther H. Lips,Petra M. Nederlof,Marcel Smid,Harmen J.G. van de Werken,Roland Kanaar,John W.M. Martens,Agnes Jager,Dik C. van Gent	47
8	Conventional Autopsy versus Minimally Invasive Autopsy with Postmortem MRI, CT, and CT-guided Biopsy: Comparison of Diagnostic Performance 2018 ·Radiology ·Britt M. Blokker,Annick C. Weustink,(unknown),Jan H. von der Thüsen,(unknown),Rúben Dammers,Jan Bakker,Nomdo S. Renken,Michael A. den Bakker,Folkert J. van Kemenade,Gabriël P. Krestin,M. G. Myriam Hunink,J. Wolter Oosterhuis	38
9	The prevalence of CD146 expression in breast cancer subtypes and its relation to outcome 2017 ·Annals of Oncology ·(unknown),Anne Timmermans,Michael A. den Bakker,Anita M.A.C. Trapman,Renée Foekens,Esther Oomen‐de Hoop,Marcel Smid,Antoinette Hollestelle,Carolien H. M. van Deurzen,(unknown),John A. Foekens,John W.M. Martens,Stefan Sleijfer,(unknown)	2
10	Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study 2015 ·Annals of Surgical Oncology ·Danique L. M. van Broekhoven,Dirk J. Grünhagen,Michael A. den Bakker,Thijs van Dalen,Cornelis Verhoef	77
11	Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer 2013 ·Breast Cancer Research and Treatment ·Antoinette Hollestelle,Justine Peeters,Marcel Smid,Mieke Timmermans,Leon C. Verhoog,Pieter J. Westenend,Anouk A. J. Heine,Alan Chan,Anieta M. Sieuwerts,Erik A.C. Wiemer,Jan G.M. Klijn,Peter J. van der Spek,John A. Foekens,Mieke Schutte,Michael A. den Bakker,John W.M. Martens	103
12	A new approach for rapid and reliable enumeration of circulating endothelial cells in patients 2012 ·Journal of Thrombosis and Haemostasis ·Jaco Kraan,Michiel Strijbos,Anieta M. Sieuwerts,John A. Foekens,Michael A. den Bakker,Cornelis Verhoef,Stefan Sleijfer,Jan W. Gratama	49
13	Solitary, multifocal and generalized myofibromas: clinicopathological and immunohistochemical features of 114 cases 2012 ·Histopathology ·Lindsey Oudijk,Michael A. den Bakker,Wim C.J. Hop,Marta C. Cohen,Adrian Charles,Rita Alaggio,Cheryl M. Coffin,Ronald R. de Krijger	47
14	Protease-Activated Receptor-2 Induces Myofibroblast Differentiation and Tissue Factor Up-Regulation during Bleomycin-Induced Lung Injury 2010 ·American Journal Of Pathology ·Keren Borensztajn,Paul Bresser,Chris van der Loos,Ilze Bot,Bernt van den Blink,Michael A. den Bakker,Joost Daalhuisen,A.P. de Groot,Maikel P. Peppelenbosch,Jan H. von der Thüsen,C. Arnold Spek	49
15	Combined therapy for thyroid squamous cell carcinoma 2010 ·Head & Neck ·Filip De Vos,Aniel Sewnaik,Johannes H. W. de Wilt,Ernst J. Smid,Michael A. den Bakker,Esther van Meerten	8
16	TP53Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors 2009 ·Journal of Neuropathology & Experimental Neurology ·Robert M. Verdijk,Michael A. den Bakker,Hendrikus J. Dubbink,Wim C.J. Hop,Winand N.M. Dinjens,Johan M. Kros	42
17	Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer 2008 ·Clinical Cancer Research ·Gert G. Van den Eynden,Marcel Smid,Steven Van Laere,Cécile Colpaert,Ilse Van der Auwera,(unknown),Peter A. van Dam,Michael A. den Bakker,Luc Dirix,Eric A. Van Marck,Peter Vermeulen,John A. Foekens	23
18	Nitrofurantoin-induced pulmonary fibrosis: a case report 2008 ·Journal of Medical Case Reports ·Natascha Goemaere,(unknown),Peter Th. W. van Hal,Michael A. den Bakker	41
19	Cells meeting our immunophenotypic criteria of endothelial cells are large platelets 2007 ·Cytometry Part B Clinical Cytometry ·Michiel Strijbos,Jaco Kraan,Michael A. den Bakker,Bart N. Lambrecht,Stefan Sleijfer,Jan W. Gratama	55
20	Malignant mesenchymoma of the uterus, arising in a leiomyoma 2002 ·Histopathology ·Michael A. den Bakker,Vincent Noordhoek Hegt,(unknown),(unknown),Winand N.M. Dinjens	14

About Michael A. den Bakker

Michael A. den Bakker is a scholar working on Neurology, Rheumatology and Oncology, having authored 109 papers that have together received 3.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (14 papers) and Neuroendocrine Tumor Research Advances (13 papers). The work is most often cited by research in Oncology (1.1k citations), Rheumatology (592 citations) and Neurology (595 citations). Michael A. den Bakker has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Cornelis Verhoef, John A. Foekens, Stefan Sleijfer, Winand N.M. Dinjens, Alexander Marx, Hans Gelderblom, Jeroen S. Kloover, Danique L. M. van Broekhoven, Dirk J. Grünhagen and Jan P. van Meerbeeck. Their work appears in journals such as Journal of Clinical Oncology, Radiology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact